05/21/2024 12:00 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 11:15 PM | MEI Pharma (Filer)
| Form EFFECT | |
02/28/2024 3:04 PM | MEI Pharma (Filer)
| Form 424B5 | |
02/20/2024 4:33 PM | MEI Pharma (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
01/12/2024 3:00 PM | MEI Pharma (Issuer) Wood Steven D (Reporting)
| Form 4/A | |
01/12/2024 3:00 PM | Flynn James P (Reporting) MEI Pharma (Issuer)
| Form 4/A | |
12/26/2023 4:00 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
12/22/2023 3:00 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/20/2023 8:26 PM | MEI Pharma (Issuer) Wood Steven D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 8:25 PM | Flynn James P (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2023 7:59 PM | MEI Pharma (Issuer) Wood Steven D (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/09/2023 3:00 PM | MEI Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023 4:03 PM | MEI Pharma (Filer)
| Form DEFA14A | |
11/08/2023 4:04 PM | MEI Pharma (Filer)
| Form ARS | |
11/06/2023 4:06 PM | Datoo Taheer (Reporting) MEI Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/03/2023 5:04 PM | Flynn James P (Reporting) MEI Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/01/2023 4:15 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form DFAN14A | |
11/01/2023 4:20 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form SC 13D/A | |
11/01/2023 3:54 PM | MEI Pharma (Filer)
| Form DEFA14A | |
10/24/2023 6:32 PM | Anson Advisors Inc. (Reporting) Anson Funds Management LP (Reporting) Anson Management GP LLC (Reporting) Kassam Moez (Reporting) MEI Pharma (Issuer) Nathoo Amin (Reporting) Winson Bruce Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/24/2023 6:34 PM | Cable Car Capital LLC (Reporting) Funicular Funds, LP (Reporting) Ma-Weaver Jacob (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/24/2023 4:00 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form SC 13D/A | |
10/17/2023 4:28 PM | MEI Pharma (Subject)
| Form DEFC14A | |
10/13/2023 4:00 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form SC 13D/A | |
10/13/2023 4:02 PM | Anson Advisors Inc. (Reporting) Anson Funds Management LP (Reporting) Anson Management GP LLC (Reporting) Kassam Moez (Reporting) MEI Pharma (Issuer) Nathoo Amin (Reporting) Winson Bruce Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/13/2023 4:04 PM | Cable Car Capital LLC (Reporting) Funicular Funds, LP (Reporting) Ma-Weaver Jacob (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 6:38 PM | GHALIE RICHARD G (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 6:39 PM | KANGO SUJAY (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 6:40 PM | MEI Pharma (Issuer) Reynolds Thomas C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 6:40 PM | HOWSON TAMAR D (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 6:41 PM | GOLD DANIEL P PHD (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 6:41 PM | Glover Nicholas (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 6:41 PM | DRISCOLL FREDERICK W (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 6:42 PM | Baltic Charles V. III (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 4:25 PM | MEI Pharma (Filer)
| Form PRER14A | |
10/10/2023 2:00 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form DFAN14A | |
10/10/2023 9:33 AM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form DEFC14A | |
10/03/2023 5:33 AM | MEI Pharma (Filer)
| Form 8-A12B | |
10/03/2023 5:04 AM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/02/2023 4:27 PM | MEI Pharma (Filer)
| Form DEFA14A | |
10/02/2023 7:42 AM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form PREC14A | |
Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad) In January 2021, Donald Trump silently rolled out a special gift to the American public…
One that top house republicans called “The Key To America’s Economic Future”. You just have to make this simple move before July 30, 2024. |
09/29/2023 4:13 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form DFAN14A | |
09/28/2023 4:17 PM | MEI Pharma (Filer)
| Form DEFA14A | |
09/26/2023 4:19 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form SC 13D/A | |
09/26/2023 4:21 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form DFAN14A | |
09/26/2023 3:31 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/26/2023 3:11 PM | MEI Pharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
09/26/2023 2:42 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form DEFC14A | |
09/25/2023 6:41 PM | Cable Car Capital LLC (Reporting) Funicular Funds, LP (Reporting) Ma-Weaver Jacob (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2023 6:43 PM | Anson Advisors Inc. (Reporting) Anson Funds Management LP (Reporting) Anson Management GP LLC (Reporting) Kassam Moez (Reporting) MEI Pharma (Issuer) Nathoo Amin (Reporting) Winson Bruce Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/22/2023 8:19 PM | Cable Car Capital LLC (Reporting) Funicular Funds, LP (Reporting) Ma-Weaver Jacob (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/22/2023 8:21 PM | Anson Advisors Inc. (Reporting) Anson Funds Management LP (Reporting) Anson Management GP LLC (Reporting) Kassam Moez (Reporting) MEI Pharma (Issuer) Nathoo Amin (Reporting) Winson Bruce Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/22/2023 4:21 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form SC 13D/A | |
09/22/2023 4:24 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form DFAN14A | |
09/21/2023 7:12 PM | Klarquist Scott (Filed by) MEI Pharma (Subject)
| Form PX14A6G | |
09/18/2023 3:16 PM | MEI Pharma (Filer)
| Form DEFA14A | |
09/18/2023 8:29 AM | MEI Pharma (Subject)
| Form PREC14A | |
09/15/2023 4:29 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form SC 13D/A | |
08/04/2023 4:15 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form PRRN14A | |
08/01/2023 6:07 PM | File Justin J. (Reporting) MEI Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/27/2023 4:27 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/24/2023 8:16 AM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/19/2023 3:35 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form DFAN14A | |
07/18/2023 4:26 PM | MEI Pharma (Subject)
| Form 425 | |
07/18/2023 4:20 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/17/2023 3:34 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form SC 13D/A | |
07/17/2023 3:34 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form DFAN14A | |
07/17/2023 3:02 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/17/2023 3:03 PM | MEI Pharma (Subject)
| Form 425 | |
07/17/2023 8:15 AM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form PREC14A | |
07/13/2023 3:19 PM | MEI Pharma (Filer)
| Form 424B3 | |
07/13/2023 3:15 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/13/2023 3:17 PM | MEI Pharma (Subject)
| Form 425 | |
07/10/2023 8:10 AM | Klarquist Scott (Filed by) MEI Pharma (Subject)
| Form PX14A6G | |
07/07/2023 3:51 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/03/2023 3:56 PM | MEI Pharma (Filer)
| Form 424B3 | |
06/28/2023 5:07 AM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/28/2023 5:09 AM | MEI Pharma (Subject)
| Form 425 | |
06/20/2023 5:11 AM | MEI Pharma (Subject)
| Form 425 | |
06/20/2023 5:08 AM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2023 8:28 PM | MEI Pharma (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/13/2023 3:01 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2023 3:10 PM | MEI Pharma (Subject)
| Form 425 | |
06/06/2023 11:15 PM | MEI Pharma (Filer)
| Form EFFECT | |
06/06/2023 3:37 PM | MEI Pharma (Issuer) Urso David M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 7:54 PM | MEI Pharma (Filer)
| Form S-4/A | |
06/02/2023 7:15 AM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/02/2023 7:20 AM | MEI Pharma (Subject)
| Form 425 | |